GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Effective Interest Rate on Debt %

RAPP (Rapport Therapeutics) Effective Interest Rate on Debt % : 0.00% (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Rapport Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Rapport Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was $0.00 Mil. Rapport Therapeutics's average total debt for the quarter that ended in Mar. 2025 was $4.66 Mil. Therefore, Rapport Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 0.00%.


Rapport Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Rapport Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapport Therapeutics Effective Interest Rate on Debt % Chart

Rapport Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
- - -

Rapport Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rapport Therapeutics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Rapport Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapport Therapeutics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapport Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Rapport Therapeutics's Effective Interest Rate on Debt % falls into.


;
;

Rapport Therapeutics Effective Interest Rate on Debt % Calculation

Rapport Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  0/( (2.146+1.476)/ 2 )
=-1  *  0/1.811
=0.00 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1.476 + 0.67
=2.146

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.739 + 0.737
=1.476

Rapport Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  0/( (1.476+7.842)/ 2 )
=-1  *  0/4.659
=0.00 %

where

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.739 + 0.737
=1.476

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=6.834 + 1.008
=7.842

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Rapport Therapeutics  (NAS:RAPP) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Rapport Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Rapport Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapport Therapeutics Business Description

Industry
Traded in Other Exchanges
N/A
Address
1325 Boylston Street, Suite 401, Boston, MA, USA, 02215
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.